Health Treatment using AI: Pierre-Luc Déziel leads a discussion on the legal and ethical issues of artificial intelligence in health
On December 5, 2019 in the PEPS at Université Laval, our member Pierre-Luc Déziel lead the panel discussion “Health Treatment using AI” as part of his SynergIA series of public seminars. The team from the Institute of Applied Ethics (IDÉA) recently uploaded the event, which is now available for viewing on YouTube.
Health Treatment using artificial intelligence?
By allowing the discovery of new diagnoses or new treatments, the use of AI in health sciences contributes to the emergence of knowledge that generates significant benefits for society.
However, the development of precision medicine requires the processing of massive amounts of personal health data, particularly sensitive information whose handling is governed by confidentiality regimes. Researchers wishing to use this data must obtain prior authorizations directly from patients or public organizations. These processes can be time consuming, expensive and dissuasive.
The objectives of this seminar, presented in December 2019, were:
- to explain how AI can be a vector of progress in the medical field,
- and to reflect on how certain new modes of health data governance, such as data trusts, can be used to improve the protection of patient privacy and promote the responsible development of precision medicine.
- Alexandre Le Bouthillier, Co-founder and Chief business officer, ImagIA
- Prof. Caroline Sirois, Faculty of Pharmacy, Université Laval
- Prof. Philippe Després, Faculty of Science and Engineering, Université Laval
- Cécile Petitgand, Postdoctoral researcher, CHUM Research Centre
Moderator: Prof. Pierre-Luc Déziel, Faculty of Law, Université Laval
Let’s keep in touch!
Would you like to be informed about IID news and activities? Subscribe now to our monthly newsletter.